Clinical Trials Browser

Phase 2 × folfirinox × 90 days × Clear all

NCT04589234 2026-05-14

Saltikva for Metastatic Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms